Detail akcie PharmaCom online

Business Summary: PharmaCom BioVet Inc., formerly ABV Gold Inc., intends to introduce and further develop bone marrow transplantation and other cancer treatment procedures to benefit companion animals (canine and feline) that are diagnosed with lymphoma, other types of cancers and other diseases. The Company is introducing canine bone marrow transplantation. ABV Gold Inc. was a gold and precious metals mining company founded as an exploration company to locate, explore and mine deposits. The Company holds claims in three different properties: The Toiyabe Uranium, the Parin Mining, and the Dun Glen properties.
Financial Summary: BRIEF: For the nine months ended 30 September 2004, PharmaCom BioVet Inc. revenues was not reported. Net loss increased from $140K to $977K. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.25 to -$0.89.